Myhep All Tablet is a prescription antiviral medicine containing sofosbuvir 400 mg and velpatasvir 100 mg. It is used to treat chronic hepatitis C virus (HCV) infection in adults. The two active ingredients work against different proteins involved in HCV replication, helping suppress the virus and allowing the body to clear the infection.

Hepatitis C can remain unnoticed for years while gradually damaging the liver. Effective antiviral treatment can help eliminate HCV and reduce the risk of serious liver complications. Myhep All Tablet should therefore be used under the supervision of a qualified healthcare professional rather than as a self-treatment product. The appropriate regimen depends on your HCV status, liver condition, previous treatment, and other medicines.

How Myhep All Tablet Works

Myhep All Tablet combines two direct-acting antiviral medicines: sofosbuvir and velpatasvir. Sofosbuvir blocks the HCV NS5B polymerase, an enzyme the virus needs to reproduce its genetic material. Velpatasvir inhibits the HCV NS5A protein, another protein essential for viral replication. By targeting these different stages of the viral life cycle, the combination strongly suppresses HCV replication.

This combination provides coverage against HCV genotypes 1, 2, 3, 4, 5, and 6 in appropriate patients. In U.S. prescribing information for the equivalent sofosbuvir/velpatasvir combination, treatment commonly lasts 12 weeks for adults without cirrhosis or with compensated cirrhosis, while patients with decompensated cirrhosis require specialist-directed treatment with ribavirin.

Benefits and Expected Results

The principal benefit of Myhep All Tablet is its ability to suppress chronic HCV and help achieve a sustained virologic response (SVR), meaning that HCV RNA remains undetectable after treatment. Achieving SVR is generally considered a virologic cure, although it does not protect a person from becoming infected with hepatitis C again.

Clinical studies of sofosbuvir/velpatasvir have demonstrated high rates of sustained virologic response across several HCV patient groups. However, individual results vary, and your doctor should determine whether this medicine is appropriate for you.

How to Take Myhep All Tablet

Take Myhep All Tablet exactly as prescribed. The standard adult dose for the 400 mg/100 mg sofosbuvir/velpatasvir combination is one tablet once daily, with or without food. Take it at approximately the same time every day to maintain consistent medicine levels.

Do not stop treatment early simply because you feel better. HCV infection may cause few or no symptoms, so feeling well does not necessarily mean that the virus has been eliminated. Completing the prescribed course gives the treatment the best opportunity to work effectively.

If you miss a dose, follow your prescriber’s or pharmacist’s instructions. Do not routinely double the next dose without professional advice.

Important Safety Information

Before starting Myhep All Tablet, tell your healthcare professional about every medicine, supplement, and herbal product you use. Drug interactions can affect treatment effectiveness or cause serious adverse effects.

Your healthcare professional should also evaluate you for current or previous hepatitis B infection before starting sofosbuvir/velpatasvir. Hepatitis B reactivation has occurred during or after treatment with direct-acting antiviral medicines and can sometimes become serious.

Particular caution is necessary with amiodarone. Combining amiodarone with sofosbuvir/velpatasvir can cause significant symptomatic slowing of the heart rate, and the combination is generally not recommended unless there are no suitable alternatives and appropriate monitoring is available.

Acid-reducing medicines can also interact with velpatasvir. Tell your doctor if you use antacids, H2-receptor blockers, or proton-pump inhibitors so that the timing and suitability of treatment can be assessed.

Possible Side Effects

Most people tolerate sofosbuvir/velpatasvir well. Commonly reported adverse effects include headache and fatigue. Other symptoms can occur, and their severity can differ from person to person.

Seek medical advice promptly if you experience severe symptoms, signs of an allergic reaction, unusual heartbeat, significant weakness, or other concerning changes during treatment. Do not assume that every new symptom comes from the medicine; your healthcare professional can determine the cause.

Who Should Use Myhep All Tablet?

Myhep All Tablet is intended for people diagnosed with chronic hepatitis C who have been evaluated by a healthcare professional. Doctors may assess HCV RNA, genotype when relevant, liver function, fibrosis or cirrhosis status, hepatitis B status, kidney function, previous HCV treatment, and potential drug interactions before selecting therapy.

Patients with advanced liver disease require especially careful medical management. The U.S. prescribing information for sofosbuvir/velpatasvir recommends combination with ribavirin for patients with decompensated cirrhosis, demonstrating why treatment should be individualized rather than purchased and taken without medical assessment.

Storage and Handling

Keep Myhep All Tablet in its original packaging and store it according to the manufacturer’s labeled storage instructions. Keep medicines away from excessive heat and moisture and out of reach of children. Do not use tablets that appear damaged or whose packaging has been compromised.

Because Myhep All Tablet is a prescription medicine, purchase it only through a legitimate, licensed pharmacy and use it according to a valid prescription. Avoid websites offering unusually cheap products without prescription verification, because counterfeit or improperly stored medicines can put treatment at risk.

Why Choose Appropriate HCV Treatment?

Untreated chronic hepatitis C can progressively damage the liver and may lead to cirrhosis, liver failure, or liver cancer. Modern direct-acting antiviral therapy has transformed hepatitis C treatment by providing highly effective oral regimens for many patients.

Myhep All Tablet offers a convenient fixed-dose combination of two antiviral medicines in a single tablet. Its once-daily administration can make it easier for eligible patients to follow their prescribed treatment plan.

If your healthcare professional has prescribed Myhep All Tablet, use it consistently and attend recommended follow-up appointments. Confirm that your pharmacy supplies an authentic, properly packaged product before starting treatment.

Frequently Asked Questions

1. What is Myhep All Tablet used for?

Myhep All Tablet contains sofosbuvir 400 mg and velpatasvir 100 mg and is used for treating chronic hepatitis C infection in appropriate patients.

2. Can Myhep All Tablet cure hepatitis C?

Sofosbuvir/velpatasvir treatment can achieve sustained virologic response, which is generally considered a virologic cure. However, treatment success depends on the patient’s circumstances and adherence, and hepatitis C can be acquired again after successful treatment.

3. How long do I take Myhep All Tablet?

Treatment duration depends on your diagnosis and liver status. A common adult regimen is 12 weeks, but patients with advanced liver disease may require a different regimen. Always follow your specialist’s prescription.

4. Can I take Myhep All Tablet with food?

Yes. The adult sofosbuvir/velpatasvir tablet can generally be taken with or without food. Taking it consistently at the same time each day can help you maintain adherence.

5. What are the common side effects?

Headache and fatigue are among the most common adverse reactions reported with the sofosbuvir/velpatasvir combination.